Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity-Reference-Cited by-同舟云学术

Nanomaterials‐Mediated Co‐Stimulation of Toll‐Like Receptors and CD40 for Antitumor Immunity

Published:2022-10-17 Issue:47 Volume:34 Page:2207486
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Yan Jingyue¹,Zhang Yuebao¹,Du Shi¹,Hou Xucheng¹,Li Wenqing¹,Zeng Chunxi¹,Zhang Chengxiang¹,Cheng Jeffrey¹,Deng Binbin²,McComb David W.²³,Zhao Weiyu¹,Xue Yonger¹,Kang Diana D.¹,Cheng Xiaolin⁴,Dong Yizhou¹⁵^ORCID

Affiliation:

1. Division of Pharmaceutics & Pharmacology College of Pharmacy The Ohio State University Columbus OH 43210 USA

2. Center for Electron Microscopy and Analysis The Ohio State University Columbus OH 43212 USA

3. Department of Materials Science and Engineering The Ohio State University Columbus OH 43210 USA

4. Division of Medicinal Chemistry and Pharmacognosy College of Pharmacy The Ohio State University Columbus OH 43210 USA

5. Department of Radiation Oncology, Department of Biomedical Engineering The Center for Clinical and Translational Science The Comprehensive Cancer Center Dorothy M. Davis Heart & Lung Research Institute Center for Cancer Engineering, Center for Cancer Metabolism Pelotonia Institute for Immune‐Oncology The Ohio State University Columbus OH 43210 USA

Funder

National Institute of General Medical Sciences

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202207486

Reference60 articles.

1. Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy

2. Towards personalized, tumour-specific, therapeutic vaccines for cancer

3. Adoptive cell transfer: a clinical path to effective cancer immunotherapy